Niacinamide
60/100
Review before taking
- Niacin: 500mg is 14.3× the Tolerable Upper Intake Level (35mg)
- 100% of ingredients have research evidence
C
Label Compliance Grade
Product Label
Have a supplement label? Find it here.
Upload a photo of any supplement label to search our database of 92,312 products.
Safety Alerts
⚠️ Niacin: 500mg is 14.3× the Tolerable Upper Intake Level (35mg)
This product received a low score because its niacin content is more than 14 times higher than the recommended maximum daily limit of 35mg.
Label Data
1 Tablet(s)
Serving Size
Vitamin
Product Type
100%
Evidence Coverage
Supplement Facts — Evidence Check
500 mg
(2500% DV)
⚠️ Exceeds Tolerable Upper Intake Level by 14.3× (UL: 35 mg)
📚 193 studies (Tier A: 5, B: 63)
Other Ingredients
Microcrystalline Cellulose
Dicalcium Phosphate
Croscarmellose Sodium
Stearic Acid
Hypromellose
Magnesium Stearate
Silicon Dioxide
Triacetin
Polyethylene Glycol
Carnauba Wax
Label Claims — Verification
❓
All Other
❓
Structure/Function
All Other (97% of products)
Structure/Function (86% of products)
Nutrient (36% of products)
Target Groups
Adult (18 - 50 Years)
Gluten Free
Sugar Free
Product Information
📋 Directions for Use
Directions: Adults take one tablet daily.
⚠️ Warnings & Precautions
Warning: Do not take if you are pregnant or lactating.
🧪 Formulation Notes
Vitamin B-3 500 mg
Gluten-free Sugar-free Preservative-free
Additional Information
Promotes Energy Metabolism*
Keep bottle tightly closed. Store away from heat and moisture.
An FDA Regulated Facility
Niacinamide is a specific form of niacin and is also known as vitamin B-3. Niacinamide does not cause a niacin flush.
POTENCY & QUALITY GUARANTEED
2752-2b
847-255-1600
Product Details
Research Evidence
241
Research Sources
55
Avg Quality Score
113
Meta Analysis
75
Systematic Review
32
Rct
11
Clinical Trial
3
Other
3
Regulatory Source
1
Cochrane Review
1
Narrative Review
1
Openfda Safety
A
Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
A
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
A
A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
A
Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
B
Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Compare Similar Products
Rezistaf
LifeLink
100
Coenzymated B-3 25 mg
Source Naturals
100
Vitamin B Complex
Simply Supplements
100
Test X180 Boost
Force Factor
100
8-Hour Alert
MHP Maximum Human Performance
100